Latest Cord blood Stories
New research has found that stem cells derived from human cord blood could be an effective alternative in repairing heart attacks. At least 20 million people survive heart attacks and strokes every year, according to World Health Organization estimates, but many have poor life expectancy and require continual costly clinical care. The use of patient’s own stem cells may repair heart attacks, although their benefit may be limited due to scarce availability and ageing. The researchers...
LAS VEGAS, Oct. 12, 2011 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that its Board of Directors will conduct a process to explore and evaluate strategic alternatives for Cord Blood America to enhance shareholder value. Cord Blood America has not set a timetable for...
RANCHO CORDOVA, Calif., Oct. 11, 2011 /PRNewswire/ -- ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that its submission for approval of the AXP® AutoXpress® (AXP) which is used to concentrate stem cells from cord blood, has been accepted by the State Food & Drug Administration (SFDA) in China. This represents the successful completion of product testing and the administrative...
NEW YORK, Oct. 3, 2011 /PRNewswire/ -- Americord Registry, a leader in the advancement of cord blood and placenta stem cell preservation, has launched a reimbursement program for parents of children diagnosed with cerebral palsy and other acquired neurological conditions, such as perinatal asphyxia or brain damage, caused by oxygen deprivation during birth. (Logo: http://photos.prnewswire.com/prnh/20110209/NY44693LOGO ) Americord will reimburse the full cost of cord blood processing and...
A $12 million, five-year grant from the National Cancer Institute will help researchers from The University of Texas MD Anderson Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and The Methodist Hospital improve outcomes of cord blood transplantation in children and adults with cancer. The collaboration brings together a team with research experience in cancer immunology, viral immunology, cord blood transplantation, adoptive...
HONG KONG, Sept. 28, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company has filed with the U.S. Securities and Exchange Commission its Annual Report on Form 20-F, which included audited financial statements for the fiscal year ended March 31, 2011. The Form 20-F can be...
LAS VEGAS and BUENOS AIRES, Argentina, Sept. 27, 2011 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today updated shareholders on the progress of Biocordcell Argentina S.A. (BioCells, Inc.), which is 50.1 percent owned by Cord Blood America. "January through August revenues in 2011...
LAS VEGAS, Sept. 19, 2011 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, is pleased to announce that it has received all State licenses and Federal registrations required to operate as a cord blood bank in the United States. These licenses include licenses from the State of New...
All stem cells—regardless of their source—share the remarkable capability to replenish themselves by undergoing self-renewal. Yet, so far, efforts to grow and expand scarce hematopoietic (or blood-forming) stem cells in culture for therapeutic applications have been met with limited success. Now, researchers at the Stowers Institute for Medical Research teased apart the molecular mechanisms enabling stem cell renewal in hematopoietic stem cells isolated from mice and successfully...
Help beat Ohio State and "Be a Hero at the Big House" Nov. 16 at U-M's largest drive for organ, blood, tissue and bone marrow donors ANN ARBOR, Mich., Sept. 15, 2011 /PRNewswire-USNewswire/ -- Tucker Schumacher was just a baby when his parents got the nightmarish news. Their little guy was very sick, and just to survive, he needed a crucial organ transplant. At 14 months old, little Tucker got a liver transplant at C.S. Mott Children's Hospital. Now he's 18, entering his senior year of high...
